Lopinavir/ritonavir treatment induces oxidative stress and caspase-independent apoptosis in human glioblastoma U-87 MG cell line

Rossella Gratton, Paola Maura Tricarico, Rafael Lima Guimarães, Fulvio Celsi, Sergio Crovella

Research output: Contribution to journalArticle

Abstract

Background: Lopinavir and Ritonavir (LPV/r) treatment is widely used to prevent HIV mother-to-child transmission. Nevertheless, studies related to the impact of these compounds on patients, in particular in the foetus and newborns, are strictly required due to the controversial findings reported in the literature concerning possible neurologic side effects following the administration of these drugs. Objectives: In our study, we evaluated the impact of LPV/r treatment on the human glioblastoma U-87 MG cell line. Methods: In order to evaluate the influence of Lopinavir and Ritonavir in terms of oxidative stress (ROS production), mitochondrial morphology and apoptotic cell death, the latter either in the presence or in the absence of caspase-3 and-9 inhibitors, we treated U-87 MG with increasing doses (0.1-1-10-25-50 μM) of Lopinavir and Ritonavir for 24h, either in single formulation or in combination. ROS production was measured by flow cytometry using H2DCFDA dye, mitochondrial morphology was evaluated using MitoRed dye and apoptotic cell death was monitored by flow cytometry using Annexin V-FITC and Propidium Iodide. Results: We observed that co-treatment with Lopinavir and Ritonavir (25 and 50 μM) promoted a significant increase in ROS production, caused mitochondrial network damage and induced apoptosis in a caspase-independent manner. Conclusion: Based on our findings, concordant with others reported in the literature, we hypothesize that LPV/r treatment could not be entirely free from side effects, being aware of the need of validation in in vivo models, necessary to confirm our results.

Original languageEnglish
Pages (from-to)106-112
Number of pages7
JournalCurrent HIV Research
Volume16
Issue number2
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Lopinavir
Ritonavir
Glioblastoma
Caspases
Oxidative Stress
Apoptosis
Cell Line
Flow Cytometry
Cell Death
Coloring Agents
Therapeutics
Caspase 9
Propidium
Fluorescein-5-isothiocyanate
Annexin A5
Caspase 3
Nervous System
Fetus
Mothers
HIV

Keywords

  • Apoptosis
  • Caspase-independent apoptosis
  • Mitochondrial damage
  • Protease inhibitors
  • ROS
  • U87-MG glioblastoma cell line

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Lopinavir/ritonavir treatment induces oxidative stress and caspase-independent apoptosis in human glioblastoma U-87 MG cell line. / Gratton, Rossella; Tricarico, Paola Maura; Guimarães, Rafael Lima; Celsi, Fulvio; Crovella, Sergio.

In: Current HIV Research, Vol. 16, No. 2, 01.01.2018, p. 106-112.

Research output: Contribution to journalArticle

@article{02dffa6cd89b486fb70a41300e56c1cd,
title = "Lopinavir/ritonavir treatment induces oxidative stress and caspase-independent apoptosis in human glioblastoma U-87 MG cell line",
abstract = "Background: Lopinavir and Ritonavir (LPV/r) treatment is widely used to prevent HIV mother-to-child transmission. Nevertheless, studies related to the impact of these compounds on patients, in particular in the foetus and newborns, are strictly required due to the controversial findings reported in the literature concerning possible neurologic side effects following the administration of these drugs. Objectives: In our study, we evaluated the impact of LPV/r treatment on the human glioblastoma U-87 MG cell line. Methods: In order to evaluate the influence of Lopinavir and Ritonavir in terms of oxidative stress (ROS production), mitochondrial morphology and apoptotic cell death, the latter either in the presence or in the absence of caspase-3 and-9 inhibitors, we treated U-87 MG with increasing doses (0.1-1-10-25-50 μM) of Lopinavir and Ritonavir for 24h, either in single formulation or in combination. ROS production was measured by flow cytometry using H2DCFDA dye, mitochondrial morphology was evaluated using MitoRed dye and apoptotic cell death was monitored by flow cytometry using Annexin V-FITC and Propidium Iodide. Results: We observed that co-treatment with Lopinavir and Ritonavir (25 and 50 μM) promoted a significant increase in ROS production, caused mitochondrial network damage and induced apoptosis in a caspase-independent manner. Conclusion: Based on our findings, concordant with others reported in the literature, we hypothesize that LPV/r treatment could not be entirely free from side effects, being aware of the need of validation in in vivo models, necessary to confirm our results.",
keywords = "Apoptosis, Caspase-independent apoptosis, Mitochondrial damage, Protease inhibitors, ROS, U87-MG glioblastoma cell line",
author = "Rossella Gratton and Tricarico, {Paola Maura} and Guimar{\~a}es, {Rafael Lima} and Fulvio Celsi and Sergio Crovella",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1570162X16666180528100922",
language = "English",
volume = "16",
pages = "106--112",
journal = "Current HIV Research",
issn = "1570-162X",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - Lopinavir/ritonavir treatment induces oxidative stress and caspase-independent apoptosis in human glioblastoma U-87 MG cell line

AU - Gratton, Rossella

AU - Tricarico, Paola Maura

AU - Guimarães, Rafael Lima

AU - Celsi, Fulvio

AU - Crovella, Sergio

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Lopinavir and Ritonavir (LPV/r) treatment is widely used to prevent HIV mother-to-child transmission. Nevertheless, studies related to the impact of these compounds on patients, in particular in the foetus and newborns, are strictly required due to the controversial findings reported in the literature concerning possible neurologic side effects following the administration of these drugs. Objectives: In our study, we evaluated the impact of LPV/r treatment on the human glioblastoma U-87 MG cell line. Methods: In order to evaluate the influence of Lopinavir and Ritonavir in terms of oxidative stress (ROS production), mitochondrial morphology and apoptotic cell death, the latter either in the presence or in the absence of caspase-3 and-9 inhibitors, we treated U-87 MG with increasing doses (0.1-1-10-25-50 μM) of Lopinavir and Ritonavir for 24h, either in single formulation or in combination. ROS production was measured by flow cytometry using H2DCFDA dye, mitochondrial morphology was evaluated using MitoRed dye and apoptotic cell death was monitored by flow cytometry using Annexin V-FITC and Propidium Iodide. Results: We observed that co-treatment with Lopinavir and Ritonavir (25 and 50 μM) promoted a significant increase in ROS production, caused mitochondrial network damage and induced apoptosis in a caspase-independent manner. Conclusion: Based on our findings, concordant with others reported in the literature, we hypothesize that LPV/r treatment could not be entirely free from side effects, being aware of the need of validation in in vivo models, necessary to confirm our results.

AB - Background: Lopinavir and Ritonavir (LPV/r) treatment is widely used to prevent HIV mother-to-child transmission. Nevertheless, studies related to the impact of these compounds on patients, in particular in the foetus and newborns, are strictly required due to the controversial findings reported in the literature concerning possible neurologic side effects following the administration of these drugs. Objectives: In our study, we evaluated the impact of LPV/r treatment on the human glioblastoma U-87 MG cell line. Methods: In order to evaluate the influence of Lopinavir and Ritonavir in terms of oxidative stress (ROS production), mitochondrial morphology and apoptotic cell death, the latter either in the presence or in the absence of caspase-3 and-9 inhibitors, we treated U-87 MG with increasing doses (0.1-1-10-25-50 μM) of Lopinavir and Ritonavir for 24h, either in single formulation or in combination. ROS production was measured by flow cytometry using H2DCFDA dye, mitochondrial morphology was evaluated using MitoRed dye and apoptotic cell death was monitored by flow cytometry using Annexin V-FITC and Propidium Iodide. Results: We observed that co-treatment with Lopinavir and Ritonavir (25 and 50 μM) promoted a significant increase in ROS production, caused mitochondrial network damage and induced apoptosis in a caspase-independent manner. Conclusion: Based on our findings, concordant with others reported in the literature, we hypothesize that LPV/r treatment could not be entirely free from side effects, being aware of the need of validation in in vivo models, necessary to confirm our results.

KW - Apoptosis

KW - Caspase-independent apoptosis

KW - Mitochondrial damage

KW - Protease inhibitors

KW - ROS

KW - U87-MG glioblastoma cell line

UR - http://www.scopus.com/inward/record.url?scp=85052231350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052231350&partnerID=8YFLogxK

U2 - 10.2174/1570162X16666180528100922

DO - 10.2174/1570162X16666180528100922

M3 - Article

C2 - 29804534

AN - SCOPUS:85052231350

VL - 16

SP - 106

EP - 112

JO - Current HIV Research

JF - Current HIV Research

SN - 1570-162X

IS - 2

ER -